Skip to main content
. Author manuscript; available in PMC: 2021 Jan 21.
Published in final edited form as: Pharm Res. 2016 Aug 19;33(12):2904–2919. doi: 10.1007/s11095-016-2012-3

Table I.

Plasma, Blood, and Tissue Concentrations at 0.5, 2 and 8 hr After i.v Administration of 12 mg/kg Vinorelbine

Sample Vinorelbine concentration (μM)
0.5 hours 2 hours 8 hours
Plasma 4.2 ± 1.3 1.6 ± 0.1 0.11 ± 0.006
Blood 4.8 ± 0.9 1.9 ± 0.5 0.11 ± 0.03
Brain 0.92 ± 0.15 0.41 ± 0.02 0.17 ± 0.03
Heart 23.4 ± 7 27 ± 1.9 12 ± 5
Lung 23 ± 3.4 25.5 ± 16.2 5.6 ± 1.3
Liver 59.2 ± 15.2 59.3 ± 14.4 32.3 ± 7
Kidney 74 ± 24.5 42 ± 4.3 24.5 ± 8
Spleen 18 ± 3.2 24 ± 3.6 13.5 ± 5
Abdominal Fat 21 ± 2.6 34.6 ± 9.4 13.5 ± 9.6
Large Intestine 7.2 ± 2.9 11.8 ± 1.7 5.3 ± 2.8
Small Intestine 28.5 ± 12.2 16.7 ± 9.4 9.62 ± 4.7
Muscle 5.2 ± 2.5 5.8 ± 0.5 2.4 ± 0.5
Bone 3.3 ± 0.8 4.7 ± 0.6 2.1 ± 1.1
Brain Metastases 1.8 (0.73–6.5) 1.7 (0.26–6.9) 0.52 (0.14–5.8)
Systemic Metastases 28 (17–29) 18.7 (5–32)

Values represent mean ± SD (n = 3), except for metastases, where the median and range are presented